NCT04695886

Brief Summary

In Myanmar, community health workers, known as malaria volunteers, have played a key role in reducing the malaria burden in the malaria control phase, providing essential malaria services in rural areas where the coverage of formal health services is limited. However, the community-delivered models that have worked well for malaria control may not work well for malaria elimination. In parallel with switching from interventions for malaria control to those for elimination, the motivation and social importance of malaria volunteers has declined along with the decline of the malaria burden. To sustain volunteer motivation, the social importance and effectiveness in the malaria elimination program, the Community-delivered Integrated Malaria Elimination model for Myanmar (CIME model) was developed based on global evidence and qualitative consultations with community members, leaders, volunteers and health stakeholders in Myanmar. This study will assess the level of effectiveness of the CIME model in increasing malaria testing by its application in an open cluster-randomised controlled stepped-wedge trial.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
6,440

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2021

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 19, 2020

Completed
13 days until next milestone

Study Start

First participant enrolled

January 1, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 5, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2021

Completed
Last Updated

January 5, 2021

Status Verified

January 1, 2021

Enrollment Period

6 months

First QC Date

December 19, 2020

Last Update Submit

January 3, 2021

Conditions

Keywords

Community-deliveredInterventioneliminationfalciparumvivaxroutine testingStepped-wedge

Outcome Measures

Primary Outcomes (1)

  • Blood examination rate

    Change in blood examination rate as determined by the number of rapid diagnostic tests (RDTs) for malaria performed per week per village

    Assessed weekly, longitudinally over 6-months

Secondary Outcomes (18)

  • Plasmodium spp. infection detected by RDT

    Assessed weekly, longitudinally over 6-months.

  • Plasmodium spp. infections reported with 24 hours

    Assessed weekly, longitudinally over 6-months.

  • Plasmodium spp. infection detected by PCR

    Assessed weekly, longitudinally over 6-months.

  • Larval source management

    Assessed weekly, longitudinally over 6-months.

  • Dengue cases

    Assessed weekly, longitudinally over 6-months.

  • +13 more secondary outcomes

Study Arms (2)

CIME intervention

EXPERIMENTAL

Community-delivered Integrated Malaria Elimination (CIME). The CIME intervention model integrates interventions for malaria, dengue, tuberculosis, childhood diarrhoea and RDT-negative fever.

Other: Community-delivered Integrated Malaria Elimination (CIME) intervention model

ICMV standard of care

NO INTERVENTION

Integrated Community Malaria Volunteer (ICMV) model - this is the current standard of care. This model involves malaria volunteers undertaking additional screening and referral services for a range of other diseases including: dengue, lymphatic filariasis, tuberculosis, HIV/AIDS and leprosy.

Interventions

Malaria: Malaria Diagnosis using RDT, treatment, referral and reporting; Prevention interventions (Behavioral Change Communication, net and repellent distribution); assisting in case and foci investigation and larval source management. Dengue: Assisting in dengue prevention; Referral of cases. Tuberculosis (TB): Detection and referral of suspected cases; Contact tracing; Directly observed treatment, short-course (DOTS) providers; defaulter tracing; follow-up sputum examinations; assisting in TB health education talks and active case detection activities. Childhood diarrhea: Prevention; Health education and Water, sanitation and hygiene (WASH) promotion; Diagnosis and dehydration assessment; Treatment and referral; Rehydration therapy using Oral Rehydration Solution (ORS) and oral Zinc tablet; assisted referral. RDT-negative fever: Prevention and health education; Symptomatic treatment with antipyretics and immediate assisted referral.

CIME intervention

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Villages in Ayeyarwaddy, Bago and Yangon Regions and Kayah State townships in Myanmar with National Malaria Control Program (NMCP) trained Integrated Community Malaria Volunteers (ICMVs).

You may not qualify if:

  • Townships
  • A township will be excluded from the study if:
  • The township does not have an NMCP provided ICMV network
  • The township has ongoing armed conflict
  • The township does not have Vector-Borne Diseases Control (VBDC) staff or malaria focal person
  • The location of the township is not geographically or politically feasible for staff from the State/Regional capital city to conduct regular supervision visits
  • Villages
  • The village is too remote and unable to execute the CIME model completely,
  • The village has a government public health facility,
  • The village has no mobile network coverage
  • The village is in the ongoing armed conflict zone , or
  • The village has an ICMV program operated by any organizations other than NMCP
  • The village has an Annual Parasite Index (API) \>=5

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Win Han Oo, Htike W, May Chan Oo, Pwint Phyu Phyu, Kyawt Mon Win, Nay Yi Yi Linn, Tun Min, Ei Phyu Htwe, Aung Khine Zaw, Kaung Myat Thu, Galau NH, Cutts JC, Simpson JA, Scott N, O'Flaherty K, Agius PA, Fowkes FJI. Effectiveness of an expanded role for community health workers on malaria blood examination rates in malaria elimination settings in Myanmar: an open stepped-wedge, cluster-randomised controlled trial. Lancet Reg Health Southeast Asia. 2024 Oct 17;31:100499. doi: 10.1016/j.lansea.2024.100499. eCollection 2024 Dec.

  • Oo WH, Thi A, Htike W, Agius PA, Cutts JC, Win KM, Yi Linn NY, Than WP, Hkawng GN, Thu KM, Oo MC, O'Flaherty K, Kearney E, Scott N, Phyu PP, Htet AT, Myint O, Lwin Yee L, Thant ZP, Mon A, Htike S, Hnin TP, Fowkes FJI. Evaluation of the effectiveness and cost effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) model in Myanmar: protocol for an open stepped-wedge cluster-randomised controlled trial. BMJ Open. 2021 Aug 13;11(8):e050400. doi: 10.1136/bmjopen-2021-050400.

MeSH Terms

Conditions

Malaria

Condition Hierarchy (Ancestors)

Protozoan InfectionsParasitic DiseasesInfectionsMosquito-Borne DiseasesVector Borne Diseases

Study Officials

  • Freya Fowkes, DPhil

    Burnet Institute

    PRINCIPAL INVESTIGATOR
  • Win Han Oo, PhD

    Burnet Institute

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Freya Fowkes, DPhil

CONTACT

Win Han Oo, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Model Details: Stepped-wedge cluster randomized control trial (one-way crossover)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2020

First Posted

January 5, 2021

Study Start

January 1, 2021

Primary Completion

July 1, 2021

Study Completion

July 1, 2021

Last Updated

January 5, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will share

De-identified individual participant data will be available after publication from the data custodian(s) to applicants who provide a sound proposal to The Ethics Review Committee on Medical Research Involving Human Subjects, Department of Medical Research, Myanmar Ministry of Health and Sports (No. 5 Ziwaka Road, Dagon PO Yangon, Myanmar; (+95) 01 375447 extension 118; ercdmr2015@gmail.com) contingent of their approval.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Supporting information will be published in peer-reviewed journals within 2 years of study completion.
Access Criteria
Supporting information can be requested from study investigators